230 related articles for article (PubMed ID: 34585628)
1. Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19.
Valipour M; Zarghi A; Ebrahimzadeh MA; Irannejad H
Cell Cycle; 2021 Nov; 20(22):2321-2336. PubMed ID: 34585628
[TBL] [Abstract][Full Text] [Related]
2. Niclosamide for Covid-19: bridging the gap.
Al-Kuraishy HM; Al-Gareeb AI; Alzahrani KJ; Alexiou A; Batiha GE
Mol Biol Rep; 2021 Dec; 48(12):8195-8202. PubMed ID: 34664162
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication.
Ghashghaeinia M; Dreischer P; Wieder T; Köberle M
Cell Cycle; 2020 Dec; 19(24):3399-3405. PubMed ID: 33305655
[TBL] [Abstract][Full Text] [Related]
4. Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease.
Prakash H; Upadhyay D; Bandapalli OR; Jain A; Kleuser B
Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106504. PubMed ID: 33147503
[TBL] [Abstract][Full Text] [Related]
5. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
[TBL] [Abstract][Full Text] [Related]
7. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
8. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis.
Jafari A; Esmaeilzadeh Z; Khezri MR; Ghasemnejad-Berenji H; Pashapour S; Sadeghpour S; Ghasemnejad-Berenji M
J Food Biochem; 2022 Oct; 46(10):e14345. PubMed ID: 35866873
[TBL] [Abstract][Full Text] [Related]
9. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
[TBL] [Abstract][Full Text] [Related]
10. Dual action anti-inflammatory/antiviral isoquinoline alkaloids as potent naturally occurring anti-SARS-CoV-2 agents: A combined pharmacological and medicinal chemistry perspective.
Valipour M; Hosseini A; Di Sotto A; Irannejad H
Phytother Res; 2023 May; 37(5):2168-2186. PubMed ID: 37039761
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
12. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.
Amere Subbarao S
Inflammopharmacology; 2021 Apr; 29(2):343-366. PubMed ID: 33723711
[TBL] [Abstract][Full Text] [Related]
13. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
Schreiber A; Viemann D; Schöning J; Schloer S; Mecate Zambrano A; Brunotte L; Faist A; Schöfbänker M; Hrincius E; Hoffmann H; Hoffmann M; Pöhlmann S; Rescher U; Planz O; Ludwig S
Cell Mol Life Sci; 2022 Jan; 79(1):65. PubMed ID: 35013790
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Flórez-Álvarez L; Yepes LM; Rugeles MT; Zapata-Builes W; Hernandez JC; Taborda NA
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833991
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Landscape of Heparin Therapy for COVID-19.
Shi C; Tingting W; Li JP; Sullivan MA; Wang C; Wang H; Deng B; Zhang Y
Carbohydr Polym; 2021 Feb; 254():117232. PubMed ID: 33357843
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
[TBL] [Abstract][Full Text] [Related]
17. p38 MAPK inhibition: A promising therapeutic approach for COVID-19.
Grimes JM; Grimes KV
J Mol Cell Cardiol; 2020 Jul; 144():63-65. PubMed ID: 32422320
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.
Bartolini D; Stabile AM; Vacca C; Pistilli A; Rende M; Gioiello A; Cruciani G; Galli F
IUBMB Life; 2022 Jan; 74(1):93-100. PubMed ID: 34390301
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Effect of Budesonide against SARS-CoV-2.
Heinen N; Meister TL; Klöhn M; Steinmann E; Todt D; Pfaender S
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
